Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Oct 30, 2023 8:38pm
218 Views
Post# 35708397

RE:RE:RE:The week ahead

RE:RE:RE:The week ahead
Hey Canadafan, I like you but do not think that you have to be so pious about all of it. We all know the history and I have been around since 2000 and have seen it all the same as you but dare not to make the same predictions as you which have not come to fruition.As for the BOD and their expertise, as experienced as they are they have not taken this company very far after 25 years and I am sure they all sit on a bunch of other boards and make money and options there too biding their time. So let's hope that this time is different and I do agree that something needs to be said but will it is the big question and will it be enough to suffice all. Oh to be a fotw and know what is going on and if offers have even been made. As for the delay we will never know, and as you said one day we will just get news so lets hope that it is news that makes a difference to all which includes patients and the shareholder value that is so often talked about but never comes to fruition YET. I am as frustrated as anyone here and sometimes just need to vent a little but as you, I try to stick to the facts and only quote from a pr or cc and if I do make a comment I try to add IMO so as to to make it sound like gospel. So let's all cheer the onc squad on and hope that they finally get it done right as they have had so many chances and should be pretty hard to screw this one up so let's get er done and start saving lives. Will we get a pr this week is hard to say but for sure an update is required at the quarterly by the company.
<< Previous
Bullboard Posts
Next >>